Shingles vaccine overview
INTRODUCTION
A vaccine to prevent shingles, a common, painful skin disease is available on the NHS to people in their 70s.
The shingles vaccine is given as a single injection into the upper arm. Unlike the flu jab, you'll only need to have the vaccination once and you can have it at any time of the year.
The shingles vaccine is expected to reduce your risk of getting shingles. If you do go on to have the disease, your symptoms may be milder and the illness shorter.
Shingles can be very painful and uncomfortable. Some people are left with pain lasting for years after the initial rash has healed. Shingles is also fatal for around 1 in 1,000 over-70s who develop it.
It's fine to have the shingles vaccine if you've already had shingles. The shingles vaccine works very well in people who have had shingles before, and it will boost your immunity against further shingles attacks.
WHO NEED TO GET VACCINATED
You're eligible for the shingles vaccine if you are aged 70 or 78 years old.
In addition, anyone who was previously eligible (born on or after 2 September 1942) but missed out on their shingles vaccination remains eligible until their 80th birthday.
When you're eligible, you can have the shingles vaccination at any time of year.
The shingles vaccine is not available on the NHS to anyone aged 80 or over because it seems to be less effective in this age group.
HOW SHINGLES VACCINE WORK
The vaccine contains a weakened chickenpox virus (varicella-zoster virus). It's similar, but not identical to, the chickenpox vaccine.
Very occasionally, people develop a chickenpox-like illness following shingles vaccination (fewer than 1 in 10,000 individuals).
SIDE EFFECTS
Like all vaccines, the shingles vaccine can cause side effects, but they're generally mild and do not last long.
Common side effects of the shingles vaccine, which occur in at least 1 in 10 people, are:
CONCLUSION
Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles within the short time.
A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.
Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com
Media Contact:
John Kimberly
Editorial Manager
Journal of Vaccines & Vaccination
Email: jvv@scholarlypub.com